PerkinElmer COVID-19 test kit receives FDA Emergency Use Authorization for sample pooling
On Oct. 29, 2020, PerkinElmer announced that its New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization…
On Oct. 29, 2020, PerkinElmer announced that its New Coronavirus Nucleic Acid Detection Kit received Emergency Use Authorization…
On Oct. 29, 2020, Takeda Pharmaceutical announced that it would import and distribute 50 million doses of Moderna’s…
On Oct. 29, 2020, Emulate announced that it had entered into a Cooperative Research and Development Agreement (CRADA)…
On Oct. 29, 2020, the University of California, Berkeley (UC Berkeley) announced that it had launched a new…
On Oct. 28, 2020, The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) announced it had begun the…
On Oct. 28, 2020, Novartis and Molecular Partners announced a collaboration in the form of an option and…
On Oct. 28, 2020, CVS Health announced plans to expand COVID-19 testing services currently offered at select CVS…
On Oct. 28, 2020, researchers at the National Institutes of Health (NIH) announced that they had discovered a…
On Oct. 28, 2020, Eli Lilly announced the New England Journal of Medicine had published data from the…
On Oct. 28, 2020, Eli Lilly announced an initial agreement with the U.S. government to supply 300,000 vials…
On Oct. 28, 2020, Abiomed announced the first two patients were treated with the Impella ECP expandable percutaneous…
On Oct. 28, 2020, researchers at the University of Nebraska Medical Center (UNMC) reported the results of a…
On Oct. 28, 2020, Regeneron announced positive, prospective results from an ongoing Phase 2/3 seamless trial in the…
On Oct. 28, 2020, University of Texas (UT) Southwestern scientists reported that an X-ray test commonly used to…
On Oct. 28, 2020, Seagen announced the closing of a $1.0 billion equity investment by Merck in 5.0…
On Oct. 27, 2020, a National Institutes of Health (NIH) study of 5,000 women found that approximately 1…
On Oct. 27, 2020, researchers from the National Institutes of Health (NIH) announced they had discovered a new…
On Oct. 27, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
On Oct. 27, 2020, Nektar Therapeutics announced that it has received FDA clearance for an Investigational New Drug…
On Oct. 27, 2020, researchers at Yale University and the Broad Institute of MIT and Harvard screened hundred…
On Oct. 27, 2020, Novavax announced updates on its Phase 3 clinical development program of NVX-CoV2373, its COVID-19…
On Oct. 26, 2020, the Department of Defense (DOD), in coordination with the Department of Health and Human…
On Oct. 26, 2020, immunologists at Scripps Research, in partnership with colleagues at the IAVI Neutralizing Antibody Center,…
On Oct. 26, 2020, Moderna announced a supply agreement with the Ministry of Public Health of Qatar for…
On Oct. 26, 2020, PerkinElmer announced that its PKamp Respiratory SARS-CoV-2 RT-PCR Panel had received clearance to be…
On Oct. 26, 2020, Bayer announced the acquisition of Asklepios BioPharmaceutical, a US-headquartered biopharmaceutical company specialized in the…
On Oct. 26, 2020, Todos Medical announced the completion of the instrument validation in its mobile lab division….
On Oct. 26, 2020, Taconic Biosciences announced immediate humanized ACE2 mouse model availability for COVID-19 research. The SARS-CoV-2…
On Oct. 26, 2020, Membrion announced it was pioneering a mask spray that binds COVID-19 molecules on the…
On Oct. 26, 2020, Todos Medical announced the completion of clinical validation and CLIA certification for MOTO+PARA’s mobile…